vs
DigitalOcean Holdings, Inc.（DOCN）与自然阳光（NATR）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是自然阳光的2.0倍（$242.4M vs $123.8M），DigitalOcean Holdings, Inc.净利率更高（10.6% vs 3.3%，领先7.3%），DigitalOcean Holdings, Inc.同比增速更快（18.3% vs 4.7%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $7.6M），过去两年DigitalOcean Holdings, Inc.的营收复合增速更高（14.5% vs 5.6%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
DOCN vs NATR — 直观对比
营收规模更大
DOCN
是对方的2.0倍
$123.8M
营收增速更快
DOCN
高出13.5%
4.7%
净利率更高
DOCN
高出7.3%
3.3%
自由现金流更多
DOCN
多$23.6M
$7.6M
两年增速更快
DOCN
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $123.8M |
| 净利润 | $25.7M | $4.1M |
| 毛利率 | 58.7% | 72.5% |
| 营业利润率 | 16.0% | 4.3% |
| 净利率 | 10.6% | 3.3% |
| 营收同比 | 18.3% | 4.7% |
| 净利润同比 | 40.5% | 1379.4% |
| 每股收益（稀释后） | $0.23 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCNNATR
| Q4 25 | $242.4M | $123.8M | ||
| Q3 25 | $229.6M | $128.3M | ||
| Q2 25 | $218.7M | $114.8M | ||
| Q1 25 | $210.7M | $113.2M | ||
| Q4 24 | $204.9M | $118.2M | ||
| Q3 24 | $198.5M | $114.6M | ||
| Q2 24 | $192.5M | $110.6M | ||
| Q1 24 | $184.7M | $111.0M |
净利润DOCNNATR
| Q4 25 | $25.7M | $4.1M | ||
| Q3 25 | $158.4M | $5.3M | ||
| Q2 25 | $37.0M | $5.3M | ||
| Q1 25 | $38.2M | $4.7M | ||
| Q4 24 | $18.3M | $-321.0K | ||
| Q3 24 | $32.9M | $4.3M | ||
| Q2 24 | $19.1M | $1.3M | ||
| Q1 24 | $14.1M | $2.3M |
毛利率DOCNNATR
| Q4 25 | 58.7% | 72.5% | ||
| Q3 25 | 59.6% | 73.3% | ||
| Q2 25 | 59.9% | 71.7% | ||
| Q1 25 | 61.4% | 72.1% | ||
| Q4 24 | 57.1% | 72.0% | ||
| Q3 24 | 60.2% | 71.3% | ||
| Q2 24 | 61.0% | 71.4% | ||
| Q1 24 | 60.7% | 71.2% |
营业利润率DOCNNATR
| Q4 25 | 16.0% | 4.3% | ||
| Q3 25 | 19.6% | 7.0% | ||
| Q2 25 | 16.3% | 3.7% | ||
| Q1 25 | 17.9% | 5.4% | ||
| Q4 24 | 15.9% | 3.8% | ||
| Q3 24 | 12.4% | 4.6% | ||
| Q2 24 | 11.6% | 5.1% | ||
| Q1 24 | 6.2% | 4.2% |
净利率DOCNNATR
| Q4 25 | 10.6% | 3.3% | ||
| Q3 25 | 69.0% | 4.2% | ||
| Q2 25 | 16.9% | 4.6% | ||
| Q1 25 | 18.1% | 4.2% | ||
| Q4 24 | 8.9% | -0.3% | ||
| Q3 24 | 16.6% | 3.8% | ||
| Q2 24 | 9.9% | 1.2% | ||
| Q1 24 | 7.7% | 2.1% |
每股收益（稀释后）DOCNNATR
| Q4 25 | $0.23 | $0.23 | ||
| Q3 25 | $1.51 | $0.30 | ||
| Q2 25 | $0.39 | $0.28 | ||
| Q1 25 | $0.39 | $0.25 | ||
| Q4 24 | $0.21 | $-0.02 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.20 | $0.07 | ||
| Q1 24 | $0.15 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $93.9M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-28.7M | $161.6M |
| 总资产 | $1.8B | $261.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCNNATR
| Q4 25 | $254.5M | $93.9M | ||
| Q3 25 | $236.6M | $95.6M | ||
| Q2 25 | $387.7M | $81.3M | ||
| Q1 25 | $360.4M | $86.5M | ||
| Q4 24 | $428.4M | $84.7M | ||
| Q3 24 | $439.9M | $78.7M | ||
| Q2 24 | $443.1M | $68.7M | ||
| Q1 24 | $419.1M | $77.8M |
总债务DOCNNATR
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
股东权益DOCNNATR
| Q4 25 | $-28.7M | $161.6M | ||
| Q3 25 | $-69.6M | $166.7M | ||
| Q2 25 | $-175.2M | $163.7M | ||
| Q1 25 | $-210.7M | $167.1M | ||
| Q4 24 | $-203.0M | $161.0M | ||
| Q3 24 | $-211.7M | $162.6M | ||
| Q2 24 | $-253.8M | $156.4M | ||
| Q1 24 | $-286.1M | $159.7M |
总资产DOCNNATR
| Q4 25 | $1.8B | $261.1M | ||
| Q3 25 | $1.7B | $264.8M | ||
| Q2 25 | $1.7B | $254.9M | ||
| Q1 25 | $1.6B | $252.7M | ||
| Q4 24 | $1.6B | $240.9M | ||
| Q3 24 | $1.5B | $245.3M | ||
| Q2 24 | $1.5B | $235.8M | ||
| Q1 24 | $1.5B | $247.3M |
负债/权益比DOCNNATR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $7.6M |
| 自由现金流率自由现金流/营收 | 12.8% | 6.1% |
| 资本支出强度资本支出/营收 | 10.8% | 1.9% |
| 现金转化率经营现金流/净利润 | 2.23× | 2.41× |
| 过去12个月自由现金流最近4个季度 | $180.5M | $28.8M |
8季度趋势，按日历期对齐
经营现金流DOCNNATR
| Q4 25 | $57.3M | $9.9M | ||
| Q3 25 | $95.8M | $18.5M | ||
| Q2 25 | $92.4M | $4.3M | ||
| Q1 25 | $64.1M | $2.6M | ||
| Q4 24 | $71.3M | $12.2M | ||
| Q3 24 | $73.4M | $9.6M | ||
| Q2 24 | $71.3M | $1.3M | ||
| Q1 24 | $66.7M | $2.2M |
自由现金流DOCNNATR
| Q4 25 | $31.1M | $7.6M | ||
| Q3 25 | $88.0M | $16.8M | ||
| Q2 25 | $59.3M | $3.0M | ||
| Q1 25 | $2.1M | $1.5M | ||
| Q4 24 | $26.1M | $10.0M | ||
| Q3 24 | $16.0M | $7.9M | ||
| Q2 24 | $39.5M | $-2.0M | ||
| Q1 24 | $23.0M | $-1.5M |
自由现金流率DOCNNATR
| Q4 25 | 12.8% | 6.1% | ||
| Q3 25 | 38.3% | 13.1% | ||
| Q2 25 | 27.1% | 2.6% | ||
| Q1 25 | 1.0% | 1.3% | ||
| Q4 24 | 12.7% | 8.5% | ||
| Q3 24 | 8.1% | 6.9% | ||
| Q2 24 | 20.5% | -1.9% | ||
| Q1 24 | 12.5% | -1.4% |
资本支出强度DOCNNATR
| Q4 25 | 10.8% | 1.9% | ||
| Q3 25 | 3.4% | 1.3% | ||
| Q2 25 | 15.2% | 1.2% | ||
| Q1 25 | 29.4% | 1.0% | ||
| Q4 24 | 22.1% | 1.9% | ||
| Q3 24 | 28.9% | 1.5% | ||
| Q2 24 | 16.6% | 3.0% | ||
| Q1 24 | 23.6% | 3.3% |
现金转化率DOCNNATR
| Q4 25 | 2.23× | 2.41× | ||
| Q3 25 | 0.60× | 3.46× | ||
| Q2 25 | 2.50× | 0.81× | ||
| Q1 25 | 1.68× | 0.55× | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | 2.23× | 2.21× | ||
| Q2 24 | 3.73× | 0.97× | ||
| Q1 24 | 4.72× | 0.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
